Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Pharmaceutical composition for treating macular hemorrhage in high myopia and application of pharmaceutical composition

A technology for macular hemorrhage and high myopia, applied in the field of medicine, can solve the problems of bleeding absorption not having any effect, unsuitable for macular hemorrhage, and the efficacy of western medicine remains to be seen, etc., and achieves the effects of mild drug properties, high safety factor, and definite curative effect.

Inactive Publication Date: 2015-05-06
陈红
View PDF3 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Clinically, surgery, injection of inert gas into the vitreous cavity, laser therapy, and symptomatic western medicine are often used for the treatment of high myopia macular hemorrhage. Macular hemorrhage; the laser can only prevent the reoccurrence of the hemorrhage, but has no effect on the absorption of the hemorrhage, and the efficacy of western medicine remains to be seen

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0028] Weigh each raw material of the present invention according to the following parts by weight: 7 parts of ginseng, 11 parts of medlar, 11 parts of longan meat, 9 parts of raspberry, 7 parts of Puhuang, 11 parts of pomegranate flower, 7 parts of Coptis chinensis, 8 parts of cassia twig, donkey-hide gelatin 6 parts, 10 parts of Panax notoginseng, 11 parts of Ligustrum lucidum, 9 parts of Plantago seed, and 10 parts of terrazzo.

[0029] The preparation process is as follows:

[0030] After pulverizing the raw materials in the above weight parts, soak for 4 hours, decoct twice for 60 minutes each time, filter, combine the filtrate, and concentrate the filtrate to a relative density of 1.16-1.18 (measured at 75°C), and wait to cool to room temperature , add ethanol to make the alcohol content reach 75%, let it stand for 12 hours, filter the supernatant, recycle the ethanol, and concentrate it to a traditional Chinese medicine extract with a relative density of 1.12-1.15 when ...

Embodiment 2

[0033] Weigh each raw material of the present invention according to the following parts by weight: 6 parts of ginseng, 10 parts of medlar, 10 parts of longan meat, 8 parts of raspberry, 6 parts of Puhuang, 10 parts of pomegranate flower, 6 parts of Coptis chinensis, 7 parts of cassia twig, Tongcao 10 parts, 8 parts of Asarum, 5 parts of donkey-hide gelatin, 8 parts of Panax notoginseng, 10 parts of kelp, 10 parts of Ligustrum lucidum, 8 parts of plantain seed, and 8 parts of terrazzo.

[0034] The preparation process is the same as in Example 1.

Embodiment 3

[0036] Weigh each raw material of the present invention according to the following parts by weight: 8 parts of ginseng, 12 parts of medlar, 12 parts of longan meat, 11 parts of raspberry, 8 parts of Puhuang, 12 parts of pomegranate flower, 8 parts of Coptis chinensis, 9 parts of cassia twig, donkey-hide gelatin 7 parts, Panax notoginseng 12 parts, Ligustrum lucidum seed 12 parts, Plantago seed 10 parts, and genus 12 parts.

[0037] The preparation process is the same as in Example 1.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
Diopteraaaaaaaaaa
Login to View More

Abstract

The invention belongs to the technical field of medicine, and in particular relates to a pharmaceutical composition for treating macular hemorrhage in high myopia and an application of the pharmaceutical composition. The pharmaceutical composition consists of the following components: ginseng, fruit of Chinese wolfberry, longan aril, raspberry, pollen typhae, pomegranate flower, coptis chinensis, cassia twig, colla corii asini, pseudo-ginseng, glossy privet fruit, semen plantaginis and Chinese starjasmine stem. The pharmaceutical composition disclosed by the invention is a pure traditional Chinese medicine pharmaceutical composition, is reasonable in formula and is applied according to syndrome differentiation, and the pharmaceutical composition has a relatively good curative effect on macular hemorrhage in high myopia, and in particular on macular hemorrhage in high myopia caused by deficiency fire and collateral injury.

Description

technical field [0001] The invention belongs to the technical field of medicine, and in particular relates to a pharmaceutical composition for treating high myopia macular hemorrhage and its application. Background technique [0002] High myopia macular hemorrhage belongs to the categories of "severe blindness", "coloured vision" and "dimmed vision" in ophthalmology of traditional Chinese medicine. It is one of the eye diseases that seriously damage the central vision. , resulting in permanent low vision or blindness. High myopia is also called pathological myopia. Due to the prolongation of the course of the disease and the lengthening of the eye axis in the posterior pole of pathological myopia, the capillaries in the macular area are damaged and macular hemorrhage occurs. High myopia macular hemorrhage can be divided into simple type and neovascular type according to whether it is accompanied by choroidal neovascularization. The main causes of the lesion include genetic ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K36/88A61P27/02A61K35/36
Inventor 赵宇
Owner 陈红
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com